# US 2016/0250331 A1 · Biodegradable Magnetic Nanoparticles and Related Methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0250331 A1
- Document ID: US20160250331A1
- Status: Published application
- Kind: A1
- Application number: 15/059,048
- Filed: 2016-03-02
- Published: 2016-09-01
- Earliest claimed: 2011-12-07
- Assignees: Regents of the University of Minnesota
- Applicants: Regents of the University of Minnesota
- Inventors: Jian-Ping Wang; Ying Jing; Shihai He
- Web page: https://patentgrep.com/patent/US20160250331A1

## CPC

- A61K 41/0052: {Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy}
- A61K 33/26: Iron; Compounds thereof
- A61K 47/02: Inorganic compounds
- A61K 49/06: Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K 49/1818: {particles, e.g. uncoated or non-functionalised microparticles or nanoparticles}
- B22F 1/054: Nanosized particles
- B22F 1/0549: {Hollow particles, including tubes and shells}
- B22F 1/0553: {Complex form nanoparticles, e.g. prism, pyramid, octahedron}
- B22F 1/08: Metallic powder characterised by particles having an amorphous microstructure
- C22C 33/003: {making amorphous alloys}
- C22C 33/006: {compositions used for making ferrous alloys}
- C22C 33/02: by powder metallurgy
- C22C 38/001: {containing N}
- C22C 38/002: {containing In, Mg, or other elements not provided for in one single group C22C38/001 - C22C38/60}
- C22C 38/007: {containing silver}
- C22C 38/02: containing silicon
- C22C 45/00: Amorphous alloys (making amorphous non-ferrous alloys C22C1/11)
- C22C 45/005: {with Mg as the major constituent}
- C22C 45/008: {with Fe, Co or Ni as the major constituent (C22C45/02, C22C45/04 take precedence)}
- C22C 45/02: with iron as the major constituent
- H01F 1/0054: {Coated nanoparticles, e.g. nanoparticles coated with organic surfactant}
- H01F 1/0063: {in a non-magnetic matrix, e.g. granular solids (granular films H01F10/007)}
- H05B 6/02: Induction heating
- H05B 6/106: {in the form of fillings}
- B22F 1/0547: {Nanofibres or nanotubes}
- B22F 1/148: Agglomerating
- B22F 9/002: {amorphous or microcrystalline}
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- H05B 2206/023: using the curie point of the material in which heating current is being generated to control the heating temperature
- Y02P 10/25: Process efficiency
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- B22F: WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER (making alloys by powder metallurgy C22C); APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- C22C: ALLOYS (treatment of alloys C21D, C22F)
- H01F: MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H05B: ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The design of biodegradable magnetic nanoparticles for use in in-vivo biomedical applications. The particles can include Fe in combination with one or more of Mg, Zn, Si, C, N, and P atoms or other particles. The nanoparticles can be degraded in-vivo after usage. The nanoparticles can cease heating upon reaching a predetermined temperature or other value.

## Claims

### Claim 1

A method for inducing cell death in a tumor, the method comprising:
magnetically heating biocompatible and biodegradable nanoparticles that are adjacent to the tumor to induce cell death in the tumor.

### Claim 2 (depends on 1)

The method of claim 1, wherein the nanoparticle comprises an alloy of Fe and at least one of Mg, or Zn.

### Claim 3 (depends on 1)

The method of claim 1, wherein the nanoparticle is maintained at a predetermined temperature to induce cell death in the tumor.

### Claim 4 (depends on 3)

The method of claim 3, maintaining the predetermined temperature is based on a magnetic property of the nanoparticles.

### Claim 5 (depends on 1)

The method of claim 1, wherein the nanoparticles cease heating when a temperature of the nanoparticles reaches a predetermined value.

### Claim 6 (depends on 1)

The method of claim 1, wherein heating the nanoparticles includes heating the nanoparticles to a temperature between 60° C.-100° C.

### Claim 7 (depends on 1)

The method of claim 1, wherein heating the nanoparticles includes heating the nanoparticles to a temperature between 40° C. to 60° C.

### Claim 8 (depends on 1)

The method of claim 1, further comprising delivering a drug with the nanoparticles.

### Claim 9 (depends on 1)

The method of claim 1, further comprising releasing a drug from the nanoparticles.

### Claim 10 (depends on 1)

The method of claim 1, wherein magnetization of the nanoparticles substantially decreases when a temperature of the nanoparticles reaches a predetermined value.

### Claim 11 (depends on 1)

The method of claim 1, wherein heating power of the nanoparticles is sensitive to an exchange coupling constant between magnetic atoms in the nanoparticles.

### Claim 12 (depends on 1)

The method of claim 1, wherein heating power of the nanoparticles is sensitive to a magnetocrystalline anisotropy constant of the nanoparticles.

### Claim 13 (depends on 1)

The method of claim 1, further comprising imaging the nanoparticles with magnetic resonant imaging.
